Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Febrile Neutropenia

• A Study of Efbemalenograstim Alfa Injection for Stage IIIB or IV NSCLC Recieving Moderate-risk Febrile Neutropenia (FN) Chemotherapy Regimen With Risk Factors
• Lapelga vs Gastrofil
• Antimicrobial Revision in Persistent Febrile Neutropenia
• Pharmacokinetics and Safety of AmBisome and DKF-5122
• Fast-track Blood Test for Suspected Fever by Deficiency of a Kind of White Blood Cells As Main Defense Against Infection
• A Trial of Fosfomycin vs Ciprofloxacin for Febrile Neutropenia
• Effect of Simvastatin on Sepsis and Febrile Neutropenia in Patients With Acute Lymphoblastic Leukemia
• CEFtolozane-Tazobactam for the Empiric Anti-bacterial Treatment of Neutropenic Fever in Hematology Patients
• Early Versus Late Stopping of Antibiotics in Children With Cancer and High-risk Febrile Neutropenia
• Amoxicillin-clavulanate Alone or in Combination With Ciprofloxacin in Low-Risk Febrile Neutropenic Adult Patients: A Prospective, Double-blind, Randomized, Non-Inferiority Multicenter, Phase III Clinical Trial.
• Injection Regimen Trial of PEG-rhG-CSF During Breast Cancer Chemotherapy
• Efficacy of Extended Infusion of β-lactam Antibiotics for the Treatment of Febrile Neutropenia in Hematologic Patients
• Cefepime vs Ceftazidime as Empirical Therapy for Neutropenic Fever
• Granulocyte Colony Stimulating Factor for for the Prevention of Febrile Neutropenia in Epithelial Ovarian Cancer
• Starting Granulocyte Colony-Stimulating Factor at 1 Day vs 3 Days Following Chemotherapy in Pediatric Cancer Patients
• G-CSF for the Prevention of Febrile Neutropenia in Gynecologic Cancer Patients
• Long-acting G-CSF for Febrile Neutropenia
• Pneumococcal Vaccination of Multiple Myeloma Patients on Novel Agents
• Prophylactic Use of PEG-rhG-CSF in Medium-high Risk of FN in Chemotherapy of Breast Cancer
• Pentaglobin in CRE and PA Neutropenic Infections
• Management of Severe Chemotherapy-induced Neutropenia in Advanced Breast Cancer
• Choosing the Best Antibiotic to Protect Friendly Gut Bacteria During the Course of Stem Cell Transplant
• A Study to Compare Administration Schedules of G-CSF (Filgrastim) for Primary Prophylaxis of Febrile Neutropenia
• Granulocyte-colony Stimulating Factors or Antibiotics for Primary Prophylaxis for Febrile Neutropenia
• Comparative Study of Ceftazidime-Avibactam Versus Standard of Care as Therapy in Febrile Neutropenic Adults With Cancer
• Intermittent G-CSF in Patients With Breast Cancer Receiving Adjuvant Docetaxel, Doxorubicin, and Cyclophosphamide (TAC)
• Short vs Prolonged Antibiotic Treatment for Hospitalized Hemato-oncology Patients With Febrile Neutropenia
• Comparison of the Pharmacodynamics of Imipenem in Patients With Febrile Neutropenia
• Short Versus Extended Antibiotic Treatment With a Carbapenem for High-risk Febrile Neutropenia in Hematology Patients With FUO
• A Phase II Study Comparing Pegylated rhG-CSF（HHPG-19K） and rhG-CSF in Breast Cancer Patients Receiving Chemotherapy
• Study of Danggui Buxue Decoction in Preventing Neutropenia
• Effectiveness of Reduced GCSF Dosing in Patients With a Low to Moderate Risk of Febrile Neutropenia
• A Study Comparing Pegylated rhG-CSF and rhG-CSF as Support to Breast Cancer Patients Receiving Chemotherapy
• Study to Reduce Duration of Antibiotic Therapy in Haematological Patients With Fever and Neutropenia
• A Study of Pegylated rhG-CSF as Support to Advanced Non-Small-Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy Receiving Chemotherapy
• Prolonged or Standard Infusion of Cefepime Hydrochloride in Treating Patients With Febrile Neutropenia
• Pharmacokinetic/Pharmacodynamic Study of Doripenem in Febrile Neutropenic Patients
• Micafungin Versus Intravenous Itraconazole as Empirical Antifungal Therapy for Febrile Neutropenic Patients With Hematological Diseases
• Daptomycin Versus Placebo in Patients With Neutropenia and Fever
• Observational Non-Interventional Study Of Febrile Neutropenia Patients To Evaluate Antibacterial Therapeutical Options
• Procalcitonin Protocol to Shorten the Antibiotic Therapy in Febrile Neutropenia
• A Pharmacokinetic Study of JK1211(Itraconazole [Itrizole]) Oral Solution in Participants With Deep Mycosis and Those With Febrile Neutropenia Suspected of Fungal Infection
• Various G-CSF Regimens to Prevent Infection During Chemotherapy
• Meropenem Versus Meropenem Plus Glycopeptide in Patients With Febrile Neutropenia After Allogenic Blood Stem Cell Transplantation
• Comparison of Teicoplanin and Vancomycin in Initial Empirical Antibiotic Regimen for Febrile Neutropenic Patients
• Early Hospital Discharge or Standard Inpatient Care in Cancer Patients Receiving Antibiotics for Febrile Neutropenia
• Ambisome and Management of Culture-negative Neutropenic Fever Unresponsive to Antibiotics
• Comparing Ciprofloxacin (CPFX) With Cefepime (CFPM) in Febrile Neutropenic Patients With Hematologic Diseases
• Treatment of Neutropenic Patients With Fever Who Are Suspected to Have A Gram Positive Infection